Oral abstracts
|
ESVC – European Society of Veterinary Cardiology |
|||
|
Thursday 5 September |
|||
|
ESVC-O-1 |
08.15-08.30 |
Gardner |
Six-lead electrocardiography in predicting subclinical hypertrophic cardiomyopathy in cats |
|
ESVC-O-2 |
08.30-08.45 |
Maffei |
New electrocardiographic algorithm for the diagnosis of fast supraventricular tachycardias in dogs |
|
ESVC-O-3 |
08.45-09.00 |
Maffei |
Twelve-lead electrocardiographic differentiation of monomorphic ventricular tachycardia versus bundle branch block in dogs |
|
ESVC-O-4 |
12.05-12.20 |
Bagardi |
Three step-based electrocardiographic algorithm for the identification of accessory pathway location in dogs with ventricular pre-excitation |
|
ESVC-O-5 |
12.20-12.35 |
Nii |
Clinical utility of pharmacological defibrillation during canine mitral valve repair |
|
ESVC-O-6 |
12.35-12.50 |
Atkinson |
Echocardiographic indices of reverse cardiac remodeling and outcome predictors in dogs undergoing mitral valve repair |
|
ESVC-O-7 |
14.25-14.40 |
Shinoda |
Tricuspid regurgitation velocity improves after mitral valve repair in dogs but is not associated with long-term mortality |
|
ESVC-O-8 |
14.40-14.55 |
Isayama |
Trigone-based sizing method and proposal for mitral valve annuloplasty surgery in dogs |
|
ESVC-O-9 |
14.55-15.10 |
Franchini |
Three-dimensional echocardiographic determinants of the age of onset of myxomatous mitral valve disease in Cavalier King Charles Spaniels dogs |
|
ESVC-O-10 |
15.10-15.25 |
Ferri |
Assessment of Pulmonary Veins Diameter in Cavalier King Charles Spaniels with Degenerative Mitral Valve Disease |
|
ESVC-O-11 |
15.25-15.40 |
Novo Matos |
Comparison of left ventricular wall measurements obtained from different echocardiographic views: a study in 408 cats |
|
ESVC-O-12 |
15.40-15.55
|
Oricco
|
Mitral to aortic velocity-time integral ratio to estimate the regurgitant fraction in dogs with myxomatous mitral valve disease |
|
ESVC-O-13 |
15.55-16.10 |
Korzybska |
Use of the Subcostal View for Obtaining Aortic Spectral Doppler Flow Velocities in Cats |
|
ESVC-O-14 |
16.10-16.25 |
Showers |
Comparison of cardiac output measurements utilizing three-dimensional transesophageal echocardiography and two-dimensional transesophageal cardiography |
|
ESVC-O-15 |
16.25-16.40 |
Kennedy |
Comparing pulmonic and aortic velocity-time integral-derived cardiac output parameters in dogs receiving intravenous fluid challenges: a preliminary study |
|
Friday 6 September 2024 |
|||
|
ESVC-O-16 |
14.25-14.40 |
Mazzarella |
Red blood cell glycocalyx damage in canine myxomatous mitral valve disease |
|
ESVC-O-17 |
14.40-14.55 |
Patata |
Echocardiographic left ventricular wall thickness in cats: the role of the breed and the body weight |
|
ESVC-O-18 |
14.55-15.10 |
Papa |
Congenital cardiopathies in cats: a retrospective analysis in a single referral centre |
|
ESVC-O-19 |
15.10-15.25 |
Pierce |
The BEAMS Study - Baseline Evaluation And Management of Scatter radiation using RADPAD radiation absorbing drapes during veterinary interventional cardiac procedures |
|
ESVC-O-20 |
15.25-15.40 |
Galanakis |
Veterinary cardiologists’ preferences regarding interventional cardiac procedures |
|
ESVC-O-21 |
15.40-15.55 |
Dickson |
Validation of a physical examination algorithm in dyspnoeic cats presenting to general practice: the RAPID CAT 2 study |
|
ESVC-O-22 |
16.30-16.45 |
Petchdee |
Rivaroxaban versus enoxaparin plus clopidogrel therapy in cats with thromboembolic disease |
|
ESVC-O-23 |
16.45-17.00 |
Merveille |
Observational longitudinal study of pulmonary hypertension in West Highland white terriers affected with canine idiopathic pulmonary fibrosis |
|
ESVC-O-24 |
17.00-17.15 |
Merveille |
Acute and chronic pulmonary thromboembolism in dogs : a prospective clinical study |
|
ESVC-O-25 |
17.15-17.30 |
Goya |
Effects of adjunct ambrisentan therapy on clinical signs, oxygenation capacity, and echocardiographic variables in dogs with pulmonary hypertension resistant to sildenafil therapy |
|
ESVC-O-26 |
17.30-17.45 |
Lombardo |
Subcutaneous furosemide therapy for chronic management of refractory congestive heart failure in dogs and cats |
|
ESVC-O-27 |
17.45-18.00 |
Murphy |
Management and short-term outcome of 74 cases of acute congestive heart failure in cats (2017-2022) |
|
SCH – Society of Comparative Hepatology |
|||
|
Thursday 5 September |
|||
|
SCH-O-1 |
08.00-08.15 |
Phillips |
Altered serum amino acids profiles in dogs with liver disease |
|
SCH-O-2 |
08.15-08.30 |
Lopez-gomez |
Effectiveness and associated adverse effects of telmisartan in the treatment of portal hypertension secondary to liver disease in dogs |
|
SCH-O-3 |
08.30-08.45 |
Dröes |
Intact thrombin generation potential in dogs with different liver diseases |
|
SCH-O-4 |
08.45-09.00 |
Habermaass |
Fecal bile acids in canine chronic liver disease: results in 46 dogs |
|
SCH-O-5 |
09.00-09.15 |
Johnston |
Does canine schistosomiasis promote hepatocellular carcinogenesis? |
|
SCH-O-6 |
09.15-09.30 |
Lubbers |
Retrospective analysis of the incidence and clinicopathological findings associated with ammonium urate urolithiasis in dogs with congenital hepatic vascular anomalies; 378 cases (2010-2023) |
|
SCH-O-7 |
09.30-09.45 |
Petibon |
Risk factors for short-term mortality of hepatic lipidosis: a multicentre retrospective study of 162 cats |
|
SCH-O-8 |
09.45-10.00 |
Fong |
Complications associated with hepatic fine needle aspiration in cats; a retrospective study |
|
SCH-O-9 |
10.00-10.15 |
Mendoza |
The effect of transdermal mirtazapine on the appetite recovery time in hospitalized cats with hepatobiliary disease: a prospective study |
|
SCH-O-10 |
10.15-10.30 |
Hernandez Perello |
Feline emphysematous cholecystitis, a descriptive study |
|
|
|
|
|
|
ESVCP – European Society of Veterinary Clinical Pathology |
|||
|
Thursday 5 September |
|||
|
ESVCP-O-1 |
14.25-14.40 |
Weber |
Performance of the VetScan Imagyst in point-of-care detection of Giardia duodenalis in canine fecal samples |
|
ESVCP-O-2 |
14.40-14.55 |
Espada Castro |
Evaluation of a gel-based method for canine major crossmatch testing |
|
ESVCP-O-3 |
14.55-15.10 |
Machiels |
Utility of the IDEXX ProCyte Dx analyser for the measurement of total cell counts in bronchoalveolar lavage fluid from dogs with lower airway disease |
|
ESVCP-O-4 |
15.10-15.25 |
Cattaneo |
Serum symmetric dimethylarginine (SDMA) concentrations are not influenced by systemic inflammation in cats |
|
ESVCP-O-5 |
15.25-15.40 |
Reeves |
The clinical utility of C-reactive protein in the discrimination of three types of common meningitis presentations in Southeast Queensland Australia |
|
ESVCP-O-6 |
15.40-15.55 |
Kaufmann |
Prospective evaluation of the utility of the predicted ionized calcium in dogs in clinical settings |
|
ESVCP-O-7 |
15.55-16.10 |
von Luckner |
Introducing novel Diagnostics of the Feline Renine Angiontensin Aldosterone System by Tandem Mass Spectrometry |
|
ESVCP-O-8 |
16.10-16.25 |
Palerme |
The Use of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Biomarker for Septic Effusions in Dogs |
|
ESVCP-O-9 |
16.25-16.40 |
Chrysovergi |
Bioactive adrenomedullin as a diagnostic and prognostic biomarker in dogs with sepsis and septic shock |
|
ESVNU – European Society of Veterinary Nephrology and Urology |
|||
|
Thursday 5 September |
|||
|
ESVNU-O-1 |
09.00-09.15 |
Rossi |
Exploring the impact of kidney biopsy on survival in dogs with glomerular disease: insights from the european veterinary renal pathology service (evrps) |
|
ESVNU-O-2 |
09.15-09.30 |
Man |
Expression of β thymosin peptides in cat kidneys and changes associated with chronic kidney disease |
|
ESVNU-O-3 |
09.30-09.45 |
Remmel |
Usefulness of parathormone, calcitriol and parathyroid glands ultrasound in differentiating acute kidney injury and acute on chronic kidney disease in dogs |
|
ESVNU-O-4 |
09.45-10.00 |
Corsaletti |
Comparison of long-term outcomes after SUB implantation in cats with and without systematic flush: a retrospective study of 128 cases (2013-2024) |
|
ESVNU-O-5 |
10.00-10.15 |
Gravgaard |
Increased Serum Amyloid A in cats with pyelonephritis |
|
ESVNU-O-6 |
10.15-10.30 |
Erika Leth Vasby |
Urinary levels of interleukin-8 in dogs with bacteriuria |
|
ESVNU-O-7 |
11.20-11.35 |
Lopez |
Evaluation of probiotic supplementation in dogs with chronic kidney disease |
|
ESVNU-O-8 |
11.35-11.50 |
Sugar |
Clinical Findings, Prognostic Factors and Outcomes of Feline Protein Losing Nephropathy secondary to glomerular disease: A Retrospective Study |
|
ESVNU-O-9 |
11.50-12.05 |
Bernard |
Effects and remanence of short-course of telmisartan or benazepril on renal function of healthy dogs: a prospective, cross-over, double-masked, placebo-controlled study |
|
Friday 6 September 2024 |
|||
|
ESVNU-O-10 |
09.00-09.15 |
Gordin |
Urinary Clusterin and Cystatin B in Dogs with Spontaneous Acute Kidney Injury |
|
ESVNU-O-11 |
09.15-09.30 |
Jaturunratsamee |
Innovation of polycystic kidney disease test kit by loop-mediated isothermal amplification |
|
ESVNU-O-12 |
09.30-09.45 |
Fidanzio |
Evaluation of serum C-reactive protein in dogs with urinary tract infections |
|
ESVNU-O-13 |
09.45-10.00 |
Lunet Marques |
New insights into the role of adrenal function in chronic kidney disease |
|
ESVNU-O-14 |
10.00-10.15 |
Pichard |
Mycoplasma-associated urethritis in dogs: A case series |
|
ESVNU-O-15 |
10.15-10.30 |
Marynissen |
Renal health in aging apparently healthy dogs: panel of serum and urinary biomarkers |
|
ESCG – European Society of Comparative Gastroenterology |
|||
|
Friday 6 September 2024 |
|||
|
ESCG-O-1 |
08.15-08.30 |
Winston |
Ursodiol Administration Modulates the Intestinal Ecosystem of Dogs and Cats |
|
ESCG-O-2 |
08.30-08.45 |
Suchodolski |
Effect of metronidazole on fecal microbiome, metabolome, and serum uremic toxins in healthy adult cats |
|
ESCG-O-3 |
08.45-09.00 |
Simpson |
Limited ingredient diets remodel the enteric microbiome and serum metabolome of dogs with food responsive enteropathy |
|
ESCG-O-4 |
09.00-09.15 |
Rowe |
Fecal Bile Acid Dysmetabolism is Correlated with Relative Abundance of Peptacetobacter hiranonis and Oscillospirales in Cats with Chronic Kidney Disease |
|
ESCG-O-5 |
09.15-09.30 |
Winston |
Multi-omic Approach Identifies Expanded Bile Acid Pools, New Microbially Conjugated Bile Acids, and Bile Acid Biotransformation Genes in the Canine and Feline Gut Microbiota |
|
ESCG-O-6 |
09.30-09.45 |
Busch |
Recovery of fecal fatty acid and sterol profiles in dogs with acute hemorrhagic diarrhea syndrome |
|
ESCG-O-7 |
09.45-10.00 |
Rowe |
Metagenomic Sequencing Identifies Specific Gut Microbes Associated with Resolution of Canine Acute Noninfectious Colitis |
|
ESCG-O-8 |
10.00-10.15 |
Chen |
Functional gene profile and targeted metabolome in dogs with chronic enteropathy |
|
ESCG-O-9 |
10.15-10.30 |
Barko |
Disruptions in microbial tryptophan catabolism are associated with fecal abundance of Bifidobacterium and disease activity indices in cats with chronic enteropathies |
|
ESCG-O-10 |
11.20-11.35 |
Benoit |
Prediction of mortality and intensive care unit length of stay in dogs with acute pancreatitis using machine learning algorithms: a pilot study on 215 dogs |
|
ESCG-O-11 |
11.35-11.50 |
Wu |
Re-evaluation of the Reference Interval and Cut-off Value for Canine Trypsin-like Immunoreactivity Assay |
|
ESCG-O-12 |
11.50-12.05 |
Sidler |
Comparison of clinical, laboratory, and ultrasonographic findings in dogs with acute pancreatitis and acute idiopathic gastrointestinal disease |
|
ESCG-O-13 |
12.05-12.20 |
Bigay |
Use of budesonide in feline chronic enteropathies: a retrospective study of 102 cases |
|
ESCG-O-14 |
12.20-12.35 |
Kaufmann |
Functional dyspepsia in dogs and humans: a comparative approach and a retrospective study of 29 canine cases |
|
ESCG-O-15
|
12.35-12.50 |
Freisleben |
Occurrence of clinical signs in young dogs with and without Giardia duodenalis infection |
|
ESVIM – European Society of Veterinary Internal Medicine |
|||
|
Saturday 7 September |
|||
|
ESVIM-O-1 |
08.00-08.15 |
Henry |
Canine chronic idiopathic rhinitis, management and outcome: a single centre retrospective observational study |
|
ESVIM-O-2 |
08.15-08.30 |
Vilcot |
Association between signalment, clinical signs and nasal diseases type and location in dogs and cats |
|
ESVIM-O-3 |
08.30-08.45 |
Neittaanmäki |
Histopathological findings in the nasal biopsies of dogs without nasal signs compared to dogs with chronic inflammatory rhinitis |
|
ESVIM-O-4 |
08.45-09.00 |
Grobman |
Evaluation of Silent Aspiration in Dogs using Videofluoroscopic Swallow Studies |
|
ESVIM-O-5 |
14.25-14.40 |
Buton |
Description and comparison of efficacy and safety of blind bronchoalveolar lavage using a sterile endotracheal tube or direct laryngo-tracheal catheterization in 51 cats |
|
ESVIM-O-6 |
14.40-14.55 |
Chang |
Presence of fungi from bronchoalveolar lavage specimens in clinical cats and dogs – a retrospective evaluation over a ten-year period |
|
ESVIM-O-7 |
14.55-15.10 |
Parreño |
Comparison of cytological findings after obtaining two consecutive samples of bronchoalveolar lavages in dogs and cats: a prospective study of 21 cases |
|
ESVIM-O-8 |
15.10-15.25 |
Robin |
Clinical and prognostic relevance of Mycoplasma felis PCR detection in feline lower respiratory tract diseases |
|
ESVIM-O-9 |
15.25-15.40 |
Johnston |
Comparison of C-reactive protein with other markers of inflammation in dogs with meningoencephalitis of unknown origin and steroid responsive meningitis-arteritis |
|
ESVIM-O-10 |
15.40-15.55 |
Petitpre |
Evaluation of C-reactive protein assay in canine bronchoalveolar lavage fluid as a biomarker of bacterial bronchopneumopathy in dogs: A multicenter prospective study |
|
ESVIM-O-11 |
16.30-16.45 |
Reguera Burgos |
Donor and Unit-Specific Factors Influencing Hemolysis in Stored Canine and Feline Packed Red Blood Cells |
|
ESVIM-O-12 |
16.45-17.00 |
Broughton |
Anaemic retinopathy in a referral population of anaemic cats |
|
ESVIM-O-13 |
17.00-17.15 |
Beriot |
General health quality-of-life questionnaires reveal subtle behavioural changes in undiagnosed hypertensive older cats |
|
ESVIM-O-14 |
17.15-17.30 |
Meler |
Drivers and challenges of modern clinical education in veterinary teaching hospitals: Using causal loop modelling to understand better the complexity of interactions at play within academic hospitals and within the broader University system |
|
ESVIM-O-15 |
17.30-17.45 |
Knopf |
Causes and outcome of systemic inflammatory response syndrome (SIRS) in dogs – analysis of 172 cases |
|
ESVIM-O-16 |
17.45-18.00 |
Bouzouraa |
Long-term follow-up of dogs treated with a chlorambucil-prednisolone combination for Steroid-Responsive Meningitis-Arteritis: a Prospective study of 12 cases |
|
ISCAID - International Society for Companion Animal Infectious Diseases |
|||
|
Friday 6 September |
|||
|
ISCAID-O-1 |
14.25-14.40 |
Zwicklbauer |
Characterization of the lymphocyte response in cats with feline infectious peritonitis during antiviral treatment using the SMART Tube technology for flow cytometry in feline full blood samples |
|
ISCAID-O-2 |
14.40-14.55 |
Meli |
Alpha-1-acid glycoprotein quantification via spatial proximity analyte reagent capture luminescence assay – validation and application as diagnostic and prognostic marker in serum and effusions of cats with feline infectious peritonitis during GS-441524 treatment |
|
ISCAID-O-3 |
14.55-15.10 |
Wenk |
Feline coronavirus loads and presence of co-infections in cats diagnosed with feline infectious peritonitis |
|
ISCAID-O-4 |
15.10-15.25 |
Cerna |
Assessment of cardiac changes in cats with feline infectious peritonitis |
|
ISCAID-O-5 |
15.25-15.40 |
Schlachet |
Unlicensed antiviral treatment with GS-441524: How are clinicians approaching feline infectious peritonitis in primary care practices ? |
|
ISCAID-O-6 |
15.40-15.55 |
Buchta |
Shorter treatment duration of 42 days with oral GS-441524 also leads to complete remission in cats with feline infectious peritonitis |
|
ISCAID-O-7 |
15.55-16.10 |
Bergamo |
Isolation of canine Leptospira Australis strains from the field in view of vaccine development |
|
ISCAID-O-8 |
16.30-16.45 |
Schmitt |
Comparison of 5 different Leptospira spp. antibody point-of-care test results in healthy dogs after vaccination against leptospirosis |
|
ISCAID-O-9 |
16.45-17.00 |
Griebsch |
Serovar Australis replaces serovar Copenhageni as the most common serovar causing Canine Leptospirosis in New South Wales, Australia - a case series (2021-2023) |
|
ISCAID-O-10 |
17.00-17.15 |
Lecot |
Potential leptospiral shedding in vaccinated and asymptomatic pack hounds: a prospective study in 56 dogs |
|
ISCAID-O-11 |
17.15-17.30 |
Evason |
Giardia assemblages with zoonotic potential are more commonly found in cats than in dogs in fecal molecular diagnostic test samples collected from the US, Canada, Asia, and Brazil |
|
ISCAID-O-12 |
17.30-17.45 |
Sørensen |
Evaluation of attitudes and behaviours related to antimicrobial prescribing in canine acute diarrhoea using discrete choice experiments |
|
ISCAID-O-13 |
17.45-18.00 |
Belshaw |
Poor awareness amongst residents in the United Kingdom (UK) of the canine and human health risks associated with imported puppies carrying non-endemic diseases |
|
ISCAID-O-14 |
18.00-18.15 |
Mauron |
Effectiveness of the implementation of a revised hygiene concept on hand hygiene compliance and colonisation of hospitalized cats and dogs with multidrug-resistant organisms |
|
ESVONC – European Society of Veterinary Oncology |
|||
|
Friday 6 September 2024 |
|||
|
ESVONC-O-1 |
15.10-15.25 |
Faroni |
A phase 2, single-arm, open-label clinical trial on adjuvant peptide-based vaccination in dogs with biologically aggressive melanoma undergoing tumor excision and lymphadenectomy |
|
ESVONC-O-2 |
15.25-15.40 |
Ubiali |
CD47 in canine round-cell tumors: an explorative flow cytometric assessment |
|
ESVONC-O-3 |
15.40-15.55 |
Maga |
Evaluation of risk factors for the development of canine Diffuse Large B-Cell Lymphoma in northern Italy |
|
ESVONC-O-4 |
16.30-16.45 |
Mourou |
Clinico-hematological profile and outcomes of acute leukemias/myelodysplastic syndromes in cats: a retrospective study of 24 cases |
|
ESVONC-O-5 |
16.45-17.00 |
Vigouroux |
Tolerability and short term efficacy of intra-arterial vinblastine for the treatment of naturally occurring lower urinary tract carcinomas in dogs |
|
ESVONC-O-6 |
17.00-17.15 |
Lane |
Bilateral anal sacculectomy in the management of apocrine gland anal sac adenocarcinoma: a retrospective assessment |
|
ESVONC-O-7 |
17.15-17.30 |
Coppola |
Presentation and treatment of feline HSA in the UK 2009-2024: a retrospective study of 74 cases |
|
ESVONC-O-8 |
17.30-17.45 |
Kapturska |
New hope in the treatment of canine hemangiosarcoma – potentiation of doxorubicin with Poly (ADP-ribose) polymerase inhibitors and repurposed propranolol |
|
ESVONC-O-9 |
17.45-18.00 |
Rolf |
Histopathological growth pattern may predict survival in dogs with splenic haemangiosarcoma post surgery; a case-control pilot study |
|
ESVE – European Society of Veterinary Endocrinology |
|||
|
Saturday 7 September |
|||
|
ESVE-O-1 |
08.15-08.30 |
Didier |
Experiences with flash glucose monitoring system in dogs and cats: a global survey of veterinary practitioners |
|
ESVE-O-2 |
08.30-08.45 |
Del Baldo
|
Assessment of serum fructosamine and glycated hemoglobin as indicators of glycemic control in diabetic dogs: a comparative study using FreeStyle Libre-derived metrics |
|
ESVE-O-3 |
08.45-09.00 |
Miceli |
Cabergoline for the treatment of feline hypersomatotropism without concurrent diabetes mellitus |
|
ESVE-O-4 |
09.00-09.15 |
Kaemper |
Does hypophysectomy cause oxytocin deficiency in cats? |
|
ESVE-O-5 |
09.15-09.30 |
Stammeleer |
Is Follow-Up Thyroid Scintigraphy Useful in Hyperthyroid Cats Treated with Radioiodine? |
|
ESVE-O-6 |
09.30-09.45 |
Lin |
Large-scale screening for cases of suspected spontaneous hypothyroidism in adult cats and description of clinical, laboratory, scintigraphic features and treatment in four affected cats |
|
ESVE-O-7 |
09.45-10.00 |
Hulsebosch |
Clinical and Laboratory Characterization of Congenital Hypothyroidism in 23 Kittens |
|
ESVE-O-8 |
10.00-10.15 |
Schwens |
Measurement of reverse triiodothyronine concentrations in healthy dogs, dogs with primary hypothyroidism and nonthyroidal illness syndrome |
|
ESVE-O-9 |
10.15-10.30 |
Miceli |
Quantitative thyroid scintigraphy for the diagnosis of subclinical hypothyroidism in dogs |
|
ESVE-O-10 |
11.20-11.35 |
Rossi |
Re-evaluating diagnostic cut-off values: impact of Immulite-2000-antibody change on canine hypercortisolism diagnosis using low-dose dexamethasone suppression test |
|
ESVE-O-11 |
11.35-11.50 |
Meunier |
Implementing salivary cortisol testing in a clinical setting: feasibility and usefulness of at-home salivary sampling to monitor trilostane treatment in dogs with Cushing’s syndrome |
|
ESVE-O-12 |
11.50-12.05 |
Torrano Guillamón |
Performance of an In-Clinic Point-of-Care Cortisol Immunoassay for dogs with hypoadrenocorticism |
|
ESVE-O-13 |
12.05-12.20 |
Da Silva |
Potential factors that influence adrenocorticotropic hormone stimulation test results in suspect addisonian dogs |
|
ESVE-O-14 |
12.20-12.35 |
van den Berg |
Canine pheochromocytoma organoids: an in vitro model to explore new treatment options |
|
ESVE-O-15 |
12.35-12.50 |
van Bokhorst |
Steroid profiling in canine adrenocortical incidentalomas |
|
ESVCN – European Society of Veterinary Comparative Nutrition |
|||
|
Saturday 7 September |
|||
|
ESVCN-O-1 |
08.00-08.15 |
Carciofi |
Amino acid supplementation preserves protein turnover rate in obese dogs under weight loss |
|
ESVCN-O-2 |
08.15-08.30 |
Carciofi |
Protein turnover of overweight and non-overweight cats fed high starch or high protein kibble diets |
|
ESVCN-O-3 |
08.30-08.45 |
Henríquez |
Environmental impacts of extruded or homemade dog foods determined by Life Cycle Assessment (LCA) |
|
ESVCN-O-4 |
08.45-09.00 |
Vecchiato |
Hermetia illucens diet improved gut microbial metabolic activity in healthy dogs |
|
ESVCN-O-5 |
09.00-09.15 |
de Souza Theodoro |
Urine as alternative fluid for the Doubly Labelled Water method use in dogs with Chronic Kidney Disease (preliminary evaluation) |
|
ESVCN-O-6 |
09.15-09.30 |
De Souza Theodoro |
Hydrolyzed poultry byproduct meal effects on inflammatory and lipid parameters of dogs |
|
ESVCN-O-7 |
09.30-09.45 |
Kavanagh |
Ultra-low fat home cooked diets improve clinical scores and albumin in dogs with protein losing enteropathy refractory to standard management with low fat diets and immunomodulation |
|
ESVCN-O-8 |
09.45-10.00 |
Mullis |
High calorie, nutrient dense diet supports body weight in dogs with malignant cancer |
|
ESVCN-O-9 |
10.00-10.15 |
Paßlack |
Impact of the dietary supplementation of sunflower oil, fish oil and lard on the urine composition and selected blood values of healthy adult cats |
|
ESVCN-O-10 |
10.15-10.30 |
Pignataro |
Analysis of the impact of nutritional supplementation on canine gut microbiota through an in vitro colonic fermentation model |